The Bridge2AI Mood Disorder Study at MIT is a part of a larger NIH study known as Bridge2AI Voice. The study is investigating how voice can be used as a biomarker for detecting and diagnosing mood disorders/mental health conditions, such as depression, bipolar disorder and schizophrenia. The study will take place in-person at MIT, take around an hour to complete, and participants will be compensated $50.00 for their time.
Eligibility criteria includes adults 18 years or older who have a clinical diagnosis of one of the mood disorders listed above and live in the Boston area. For general information, they can email research [at] b2ai.org (research[at]b2ai[dot]org). For questions specifically for MIT, they can contact: voice_study [at] mit.edu (voice_study[at]mit[dot]edu).